Concepts (220)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tissue Engineering | 41 | 2024 | 176 | 12.510 |
Why?
|
| Myocytes, Cardiac | 27 | 2020 | 618 | 6.290 |
Why?
|
| Myocardium | 18 | 2015 | 980 | 3.700 |
Why?
|
| Tissue Scaffolds | 14 | 2020 | 73 | 3.650 |
Why?
|
| Myocardial Contraction | 20 | 2020 | 261 | 3.270 |
Why?
|
| Bioengineering | 4 | 2024 | 15 | 2.870 |
Why?
|
| Heart, Artificial | 8 | 2017 | 69 | 2.740 |
Why?
|
| Heart | 8 | 2020 | 723 | 2.210 |
Why?
|
| Bioartificial Organs | 6 | 2017 | 11 | 1.890 |
Why?
|
| Rats | 34 | 2018 | 3657 | 1.870 |
Why?
|
| Fibrin | 10 | 2020 | 67 | 1.770 |
Why?
|
| Bioreactors | 10 | 2020 | 38 | 1.490 |
Why?
|
| Cells, Cultured | 21 | 2024 | 3074 | 1.380 |
Why?
|
| Heart Ventricles | 6 | 2018 | 767 | 1.380 |
Why?
|
| Cellular Reprogramming Techniques | 2 | 2020 | 22 | 1.380 |
Why?
|
| Adipogenesis | 3 | 2020 | 75 | 1.360 |
Why?
|
| Cellular Reprogramming | 2 | 2020 | 116 | 1.250 |
Why?
|
| Printing, Three-Dimensional | 3 | 2024 | 66 | 1.230 |
Why?
|
| Chitosan | 4 | 2018 | 21 | 1.140 |
Why?
|
| Bioprosthesis | 5 | 2015 | 111 | 1.120 |
Why?
|
| Rats, Inbred F344 | 15 | 2010 | 106 | 1.070 |
Why?
|
| Rats, Sprague-Dawley | 12 | 2018 | 1213 | 1.060 |
Why?
|
| Ventricular Function | 4 | 2018 | 93 | 1.050 |
Why?
|
| Bioprinting | 2 | 2024 | 9 | 0.960 |
Why?
|
| Perfusion | 4 | 2009 | 196 | 0.930 |
Why?
|
| Biomedical Engineering | 2 | 2017 | 30 | 0.900 |
Why?
|
| Animals | 41 | 2024 | 33721 | 0.900 |
Why?
|
| Purkinje Cells | 1 | 2024 | 156 | 0.840 |
Why?
|
| Organ Culture Techniques | 2 | 2016 | 155 | 0.820 |
Why?
|
| Purkinje Fibers | 1 | 2020 | 6 | 0.720 |
Why?
|
| Aortic Valve | 3 | 2022 | 426 | 0.700 |
Why?
|
| Cell Culture Techniques | 7 | 2020 | 288 | 0.660 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2020 | 78 | 0.650 |
Why?
|
| Biomedical Research | 3 | 2008 | 510 | 0.610 |
Why?
|
| Aorta | 3 | 2011 | 534 | 0.600 |
Why?
|
| Regeneration | 3 | 2015 | 202 | 0.590 |
Why?
|
| Electrocardiography | 3 | 2018 | 963 | 0.580 |
Why?
|
| Leadership | 3 | 2008 | 226 | 0.580 |
Why?
|
| Biocompatible Materials | 5 | 2020 | 123 | 0.560 |
Why?
|
| Artificial Organs | 1 | 2016 | 14 | 0.560 |
Why?
|
| Pulsatile Flow | 1 | 2016 | 133 | 0.540 |
Why?
|
| Stress, Mechanical | 4 | 2024 | 171 | 0.530 |
Why?
|
| Action Potentials | 2 | 2017 | 499 | 0.520 |
Why?
|
| Animals, Newborn | 8 | 2017 | 1007 | 0.510 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2018 | 251 | 0.480 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2015 | 58 | 0.470 |
Why?
|
| Equipment Design | 6 | 2015 | 596 | 0.470 |
Why?
|
| Gels | 4 | 2017 | 59 | 0.470 |
Why?
|
| Creativity | 3 | 2008 | 13 | 0.460 |
Why?
|
| Group Processes | 3 | 2008 | 47 | 0.450 |
Why?
|
| Cell Survival | 4 | 2024 | 816 | 0.440 |
Why?
|
| Extracellular Matrix | 1 | 2015 | 230 | 0.440 |
Why?
|
| Angina Pectoris | 1 | 2013 | 57 | 0.440 |
Why?
|
| Sternotomy | 1 | 2013 | 42 | 0.440 |
Why?
|
| Tissue Culture Techniques | 3 | 2010 | 70 | 0.430 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2020 | 1099 | 0.430 |
Why?
|
| Electric Stimulation | 5 | 2020 | 320 | 0.430 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2011 | 160 | 0.370 |
Why?
|
| Vascular Grafting | 1 | 2011 | 44 | 0.360 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2011 | 239 | 0.360 |
Why?
|
| Muscle, Smooth | 1 | 2011 | 137 | 0.360 |
Why?
|
| Coronary Artery Bypass | 1 | 2013 | 486 | 0.340 |
Why?
|
| Isoproterenol | 3 | 2020 | 106 | 0.320 |
Why?
|
| Environment Design | 1 | 2008 | 14 | 0.320 |
Why?
|
| Heart Failure | 3 | 2020 | 2125 | 0.320 |
Why?
|
| Calcium | 3 | 2009 | 1095 | 0.310 |
Why?
|
| Streptomycin | 1 | 2008 | 18 | 0.310 |
Why?
|
| Cell Aggregation | 1 | 2008 | 23 | 0.310 |
Why?
|
| Personnel Management | 1 | 2008 | 7 | 0.310 |
Why?
|
| Time Management | 1 | 2008 | 11 | 0.310 |
Why?
|
| Organizational Policy | 1 | 2008 | 51 | 0.310 |
Why?
|
| Policy Making | 1 | 2008 | 58 | 0.310 |
Why?
|
| Body Size | 1 | 2008 | 51 | 0.310 |
Why?
|
| Myocardial Infarction | 2 | 2013 | 994 | 0.310 |
Why?
|
| Models, Cardiovascular | 2 | 2022 | 170 | 0.310 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2008 | 15 | 0.300 |
Why?
|
| Organizational Objectives | 1 | 2008 | 33 | 0.300 |
Why?
|
| Thyroid Hormones | 1 | 2008 | 66 | 0.300 |
Why?
|
| Infusion Pumps | 1 | 2008 | 33 | 0.300 |
Why?
|
| Cell Count | 1 | 2008 | 251 | 0.300 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2008 | 78 | 0.300 |
Why?
|
| Humans | 27 | 2024 | 122296 | 0.300 |
Why?
|
| Heart Valves | 1 | 2008 | 52 | 0.290 |
Why?
|
| Neovascularization, Physiologic | 2 | 2008 | 209 | 0.290 |
Why?
|
| Blood Vessels | 1 | 2008 | 102 | 0.290 |
Why?
|
| Muscle, Skeletal | 2 | 2011 | 923 | 0.290 |
Why?
|
| Diffusion of Innovation | 1 | 2008 | 97 | 0.280 |
Why?
|
| Endovascular Procedures | 2 | 2024 | 711 | 0.280 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2011 | 522 | 0.280 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2008 | 282 | 0.270 |
Why?
|
| Zebrafish | 1 | 2008 | 369 | 0.260 |
Why?
|
| Muscle Cells | 1 | 2005 | 23 | 0.260 |
Why?
|
| Epinephrine | 3 | 2020 | 175 | 0.260 |
Why?
|
| Time Factors | 5 | 2024 | 6182 | 0.250 |
Why?
|
| Ventricular Function, Left | 1 | 2008 | 500 | 0.240 |
Why?
|
| Discrete Subaortic Stenosis | 1 | 2024 | 7 | 0.240 |
Why?
|
| Heart Valve Prosthesis | 1 | 2008 | 293 | 0.240 |
Why?
|
| Spheroids, Cellular | 1 | 2024 | 59 | 0.240 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2024 | 86 | 0.230 |
Why?
|
| Stenosis, Pulmonary Vein | 1 | 2024 | 19 | 0.230 |
Why?
|
| Cardiac Catheterization | 1 | 2008 | 631 | 0.230 |
Why?
|
| Models, Animal | 2 | 2020 | 465 | 0.220 |
Why?
|
| Electric Conductivity | 2 | 2020 | 89 | 0.210 |
Why?
|
| Cooperative Behavior | 3 | 2008 | 217 | 0.210 |
Why?
|
| Angioplasty, Balloon | 1 | 2024 | 161 | 0.210 |
Why?
|
| Muscle Contraction | 2 | 2016 | 186 | 0.200 |
Why?
|
| Pulmonary Veins | 1 | 2024 | 163 | 0.200 |
Why?
|
| Heart-Assist Devices | 1 | 2011 | 1022 | 0.200 |
Why?
|
| Macrophages | 1 | 2024 | 611 | 0.180 |
Why?
|
| Adrenergic Agonists | 1 | 2020 | 11 | 0.170 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2020 | 58 | 0.170 |
Why?
|
| Cell Communication | 1 | 2020 | 165 | 0.170 |
Why?
|
| Regenerative Medicine | 2 | 2011 | 29 | 0.160 |
Why?
|
| Materials Testing | 2 | 2009 | 73 | 0.160 |
Why?
|
| Membrane Potentials | 1 | 2020 | 304 | 0.160 |
Why?
|
| Staff Development | 2 | 2008 | 45 | 0.150 |
Why?
|
| Equipment Failure Analysis | 2 | 2008 | 89 | 0.150 |
Why?
|
| Stents | 1 | 2024 | 864 | 0.150 |
Why?
|
| Polymers | 2 | 2008 | 106 | 0.150 |
Why?
|
| Biomechanical Phenomena | 2 | 2008 | 235 | 0.140 |
Why?
|
| Inflammation | 1 | 2024 | 1392 | 0.140 |
Why?
|
| Gene Expression | 3 | 2017 | 1579 | 0.140 |
Why?
|
| Phenotype | 3 | 2020 | 4151 | 0.140 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 2534 | 0.130 |
Why?
|
| Motivation | 2 | 2008 | 312 | 0.130 |
Why?
|
| Cell Proliferation | 4 | 2020 | 2311 | 0.130 |
Why?
|
| Cardiovascular Diseases | 1 | 2008 | 1822 | 0.130 |
Why?
|
| Mechanical Phenomena | 1 | 2015 | 15 | 0.130 |
Why?
|
| Collagen Type I | 1 | 2015 | 110 | 0.120 |
Why?
|
| Transcription, Genetic | 1 | 2020 | 1703 | 0.120 |
Why?
|
| Electrodes | 1 | 2015 | 97 | 0.120 |
Why?
|
| Internal Mammary-Coronary Artery Anastomosis | 1 | 2013 | 13 | 0.110 |
Why?
|
| Transcription Factors | 2 | 2020 | 2578 | 0.110 |
Why?
|
| Cell Adhesion | 1 | 2014 | 321 | 0.110 |
Why?
|
| Blood Pressure | 2 | 2008 | 1314 | 0.110 |
Why?
|
| Kinetics | 2 | 2020 | 1315 | 0.100 |
Why?
|
| Cell Nucleus | 1 | 2014 | 678 | 0.100 |
Why?
|
| Aging | 1 | 2018 | 1165 | 0.100 |
Why?
|
| Feasibility Studies | 1 | 2013 | 749 | 0.090 |
Why?
|
| Vasoconstriction | 1 | 2011 | 103 | 0.090 |
Why?
|
| Software | 1 | 2015 | 670 | 0.090 |
Why?
|
| Thymus Gland | 1 | 2010 | 101 | 0.090 |
Why?
|
| Reoperation | 1 | 2013 | 807 | 0.090 |
Why?
|
| Mesoderm | 1 | 2010 | 116 | 0.090 |
Why?
|
| Vasodilation | 1 | 2011 | 191 | 0.090 |
Why?
|
| Ventricular Myosins | 1 | 2009 | 4 | 0.090 |
Why?
|
| Decanoates | 1 | 2009 | 2 | 0.090 |
Why?
|
| Equipment and Supplies | 1 | 2009 | 23 | 0.080 |
Why?
|
| Laminin | 1 | 2009 | 59 | 0.080 |
Why?
|
| Male | 5 | 2024 | 59522 | 0.080 |
Why?
|
| Polyesters | 1 | 2009 | 40 | 0.080 |
Why?
|
| Fibronectins | 1 | 2009 | 104 | 0.080 |
Why?
|
| Tetrazolium Salts | 1 | 2009 | 15 | 0.080 |
Why?
|
| Treatment Outcome | 3 | 2024 | 12045 | 0.080 |
Why?
|
| Sympathomimetics | 1 | 2008 | 11 | 0.080 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2009 | 37 | 0.080 |
Why?
|
| Stromal Cells | 1 | 2010 | 296 | 0.080 |
Why?
|
| Facility Design and Construction | 1 | 2008 | 4 | 0.080 |
Why?
|
| Diffusion Chambers, Culture | 1 | 2008 | 6 | 0.080 |
Why?
|
| Myosin Heavy Chains | 1 | 2009 | 77 | 0.080 |
Why?
|
| Ventricular Pressure | 1 | 2008 | 43 | 0.080 |
Why?
|
| Flow Injection Analysis | 1 | 2008 | 2 | 0.080 |
Why?
|
| Efficiency, Organizational | 1 | 2008 | 47 | 0.080 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2008 | 152 | 0.080 |
Why?
|
| Cell Transplantation | 1 | 2008 | 54 | 0.070 |
Why?
|
| Microscopy, Electron | 2 | 2005 | 400 | 0.070 |
Why?
|
| Length of Stay | 1 | 2013 | 1273 | 0.070 |
Why?
|
| Job Satisfaction | 1 | 2008 | 77 | 0.070 |
Why?
|
| Culture Media | 1 | 2008 | 183 | 0.070 |
Why?
|
| Female | 5 | 2024 | 64883 | 0.070 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2008 | 424 | 0.070 |
Why?
|
| Observer Variation | 1 | 2008 | 297 | 0.070 |
Why?
|
| Calcium-Binding Proteins | 1 | 2009 | 326 | 0.070 |
Why?
|
| Models, Anatomic | 1 | 2008 | 96 | 0.070 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2007 | 12 | 0.070 |
Why?
|
| Interdisciplinary Communication | 1 | 2008 | 134 | 0.070 |
Why?
|
| Silicones | 1 | 2007 | 33 | 0.070 |
Why?
|
| Child | 3 | 2024 | 24064 | 0.070 |
Why?
|
| Osteoblasts | 1 | 2008 | 151 | 0.070 |
Why?
|
| Workload | 1 | 2008 | 146 | 0.070 |
Why?
|
| Thrombin | 1 | 2007 | 60 | 0.070 |
Why?
|
| In Vitro Techniques | 1 | 2008 | 968 | 0.070 |
Why?
|
| Cell Differentiation | 2 | 2020 | 1935 | 0.070 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2009 | 231 | 0.070 |
Why?
|
| Stroke Volume | 1 | 2008 | 446 | 0.070 |
Why?
|
| Pluripotent Stem Cells | 1 | 2007 | 76 | 0.070 |
Why?
|
| Muscle Proteins | 1 | 2008 | 415 | 0.060 |
Why?
|
| Prosthesis Design | 1 | 2008 | 665 | 0.060 |
Why?
|
| Alginates | 1 | 2024 | 18 | 0.060 |
Why?
|
| Poloxamer | 1 | 2024 | 12 | 0.060 |
Why?
|
| Porosity | 1 | 2024 | 39 | 0.060 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 4282 | 0.060 |
Why?
|
| Infant, Newborn | 1 | 2018 | 8096 | 0.060 |
Why?
|
| RNA | 1 | 2008 | 578 | 0.060 |
Why?
|
| Endothelial Cells | 1 | 2008 | 527 | 0.060 |
Why?
|
| Angiography | 1 | 2024 | 214 | 0.060 |
Why?
|
| Stem Cells | 1 | 2008 | 710 | 0.050 |
Why?
|
| Models, Biological | 1 | 2008 | 1438 | 0.050 |
Why?
|
| Prospective Studies | 1 | 2013 | 5963 | 0.050 |
Why?
|
| Middle Aged | 2 | 2013 | 25640 | 0.050 |
Why?
|
| Retrospective Studies | 2 | 2024 | 15853 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 2796 | 0.050 |
Why?
|
| Computed Tomography Angiography | 1 | 2022 | 195 | 0.050 |
Why?
|
| Adrenergic Agents | 1 | 2020 | 12 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2022 | 607 | 0.040 |
Why?
|
| Biomarkers | 1 | 2009 | 2933 | 0.040 |
Why?
|
| Cytokines | 1 | 2024 | 1272 | 0.040 |
Why?
|
| Hypoxia | 1 | 2020 | 246 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2022 | 2030 | 0.030 |
Why?
|
| Mice | 1 | 2009 | 17546 | 0.030 |
Why?
|
| Thermogravimetry | 1 | 2009 | 5 | 0.020 |
Why?
|
| Calorimetry, Differential Scanning | 1 | 2009 | 6 | 0.020 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2009 | 30 | 0.020 |
Why?
|
| Tensile Strength | 1 | 2009 | 38 | 0.020 |
Why?
|
| Infant | 1 | 2024 | 12302 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2024 | 13777 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2020 | 4511 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2009 | 878 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2004 | 408 | 0.010 |
Why?
|
| Troponin T | 1 | 2004 | 245 | 0.010 |
Why?
|